Nitric Oxide-Modified Ferredoxin [4Fe-4S] Clusters
A R T I C L E S
[Fe-S] proteins can be spontaneously activated by the simple
addition of Fe2+ and SH-/S.7 A rational mechanism is that the
[Fe-S] core is delivered to apo-[Fe-S] protein by specific carrier
proteins.7
in the presence of NO(g), were elucidated.16,17 In addition, we
also demonstrated that nitrosylation of the [2Fe-2S] cluster
[S5Fe(µ-S)2FeS5]2- yielding [(NO)2FeS5]- and the reversible
transformation of complex [(NO)2FeS5]- to the [S5Fe(µ-
S)2FeS5]2- by photolysis in the presence of the NO-acceptor
reagent [(C4H8O)Fe(S,S-C6H4)2]- are consistent with reports of
the in vitro degradation of ferredoxin [2Fe-2S] clusters to DNICs
and the repair of NO-modified [2Fe-2S] ferredoxin by cysteine
desulfurase and L-cysteine.18 In this report, an exciting advance
in this topic, the transformation of DNICs into [4Fe-4S] clusters
[Fe4S4(SR)4]2- in the presence of the reduced/oxidized-form
[Fe(SPh)4]2-/1- and sulfur-donor species, was demonstrated.
NO has been demonstrated to react with the [Fe-S] clusters
of several proteins including succinate dehydrogenase, nitro-
genase, succinate-Q reductase, mitochondrial aconitase, cytosolic
aconitase, HiPIP, endonuclease III, mammalian ferrochelatase,
and SoxR to form the monomeric, EPR-active DNICs.5a,8-14
Recently, Ding and co-workers showed that when Escherichia
coli (E. coli) cells are exposed to nitric oxide, the ferredoxin
[2Fe-2S] clusters are modified to form protein-bound dinitrosyl
iron complexes. In the repair of NO-modified ferredoxin [2Fe-
2S] clusters, the dinitrosyl iron complexes can be directly
transformed back to the ferredoxin [2Fe-2S] cluster by cysteine
desulfurase (IscS) and L-cysteine in vitro with no need of the
addition of iron or any other protein components.14a,b Removal
of the dinitrosyl iron complex from ferredoxin preventing
reassembly of the [2Fe-2S] cluster suggests the iron in the
dinitrosyl iron complex may be recycled for the reassembly of
an iron-sulfur cluster in the protein.14a,b Drapier and co-workers
demonstrated that nitric oxide converts IRP-1 (iron regulatory
proteins) from a [4Fe-4S] aconitase to a trans-regulatory protein
through [Fe-S] cluster disassembly. Reversibly, NO-modified
aconitases repairing of the [4Fe-4S] clusters was also
observed.14c In addition, the [4Fe-4S] cluster of the E. coli
endonuclease III modified by NO forming the protein-bound
dinitrosyl iron complex in vitro/in vivo and the NO-modified
[4Fe-4S] cluster being efficiently repaired in aerobically growing
E. coli cells were also reported.12
Results and Discussion
Transformation of [(NO)2Fe(SR)2]- (R ) Et, Ph) into
[Fe4S3(NO)7]- (1). Consistent with the facile conversion of
DNICs [(NO)2Fe(SR)2]- into Roussin’s black salt (RBS)
[Fe4S3(NO)7]- (1) in the presence of S8 via the intermediate
[(NO)2FeS5]- observed in the previous study,18-20 quantitative
transformation of DNICs [(NO)2Fe(SEt)2]- to complex 1 was
displayed and monitored by IR νNO spectra. The shift of the
NO stretching frequency from 1715 s, 1673 s cm-1 to 1790 w,
1740 s, 1707 m cm-1 is consistent with the formation of complex
[Na-18-crown-6-ether][Fe4S3(NO)7] (1) when a THF solution
of [(NO)2Fe(SEt)2]- was reacted with S8 in a 1:1 molar ratio,
followed by the addition of HBF4 into the mixture solution
(Scheme 1a).18-20
Conversion of Complex [Fe4S3(NO)7]2- (2) into
[Fe4S4(NO)4]2- (3). The conversion of complex [Fe4S3(NO)7]2-
(2),21 obtained from reduction of complex 1 by [Na][biphenyl],
into complex [Fe4S4(NO)4]2- (3), characterized by IR, UV-vis,
and single-crystal X-ray diffraction, was carried out when
complex 2 was treated with 1.5 equiv of [Fe(SPh)4]2- and the
subsequent addition of 1/8 equiv of S8 in CH3CN at ambient
temperature (Scheme 1b).22 Quantitative conversion of complex
2 to complex 3 and [(NO)2Fe(SPh)2]- in the presence of
[Fe(SPh)4]2- and S8 was monitored by IR. The shift of IR νNO
stretching frequencies from 1748 m, 1690 s, 1660 sh cm-1 to
1743 s, 1708 s, 1697 sh cm-1 implicated the formation of the
known [(NO)2Fe(SPh)2]- accompanied by the proposed inter-
mediate [Fe4S3(SPh)(NO)4]2- (A) when complex 2 was reacted
with 1.5 equiv of [Fe(SPh)4]2- in CH3CN at room temperature
In chemistry, synthetic routes to the [2Fe-2S] clusters
[(SR)2Fe(µ-S)2Fe(SR)2]2- (R ) alkyl, aryl) were discovered
shortly after the preparation of the first [4Fe-4S] cluster, and
the isolation/characterization of mononuclear rubredoxin
[Fe(SR)4]2-/1- subsequently followed.15 Recently, the formation
pathway of the anionic {Fe(NO)2}9 DNICs [(NO)2Fe(SR)2]-
from nitrosylation of the biomimetic oxidized and reduced form
of rubredoxin [Fe(SR)4]2-/1- (R ) Ph, Et) and the reactivity of
the mononitrosyl tris(thiolate) complexes [(NO)Fe(SR)3]-, an
intermediate for the conversion of [Fe(SR)4]2-/1- into DNICs
(6) (a) Rouault, T. A.; Tong, W.-H. Nat. ReV. Mol. Cell Biol. 2005, 6,
345–351. (b) Balk, J.; Lill, R. ChemBioChem 2004, 5, 1044–1049.
(c) Gerber, J.; Lill, R. Mitochondrion 2002, 2, 71–86. (d) Fontecave,
M.; Ollagnier-de Choudens, S. Arch. Biochem. Biophys. 2008, 474,
226–237.
(16) Harrop, T. C.; Song, D. T.; Lippard, S. J. J. Am. Chem. Soc. 2006,
128, 3528–3529.
(7) Lill, R.; Muhlenhoff, U. Trends Biochem. Sci. 2005, 30, 133–141.
(8) Kennedy, M. C.; Antholine, W. E.; Beinert, H. J. Biol. Chem. 1997,
272, 20340–20347.
(17) Lu, T.-T.; Chiou, S.-J.; Chen, C.-Y.; Liaw, W.-F. Inorg. Chem. 2006,
45, 8799–8806.
(18) Tsai, M.-L.; Chen, C.-C.; Hsu, I.-J.; Ke, S.-C.; Hsieh, C.-H.; Chiang,
K.-A.; Lee, G.-H.; Wang, Y.; Liaw, W.-F. Inorg. Chem. 2004, 43,
5159–5167.
(9) Salerno, J. C.; Ohnishi, T.; Lim, J.; King, T. E. Biochem. Biophys.
Res. Commun. 1976, 73, 833–840.
(10) Meyer, J. Arch. Biochem. Biophys. 1981, 210, 246–256.
(11) Welter, R.; Yu, L.; Yu, C.-A. Arch. Biochem. Biophys. 1996, 331,
9–14.
(19) (a) Chen, T.-N.; Lo, F.-C.; Tsai, M.-L.; Shih, K.-N.; Chiang, M.-H.;
Lee, G.-H.; Liaw, W.-F. Inorg. Chim. Acta 2006, 359, 2525–2533.
(b) Butler, A. R.; Glidewell, C.; Hyde, A. R.; Walton, J. C. Polyhedron
1985, 4, 797–809.
(12) Rogers, P. A.; Eide, L.; Klungland, A.; Ding, H. DNA Repair 2003,
2, 809–817.
(20) (a) Tsai, F.-T.; Chiou, S.-J.; Tsai, M.-C.; Tsai, M.-L.; Huang, H.-W.;
Chiang, M.-H.; Liaw, W.-F. Inorg. Chem. 2005, 44, 5872–5881. (b)
Hung, M.-C.; Tsai, M.-C.; Lee, G.-H.; Liaw, W.-F. Inorg. Chem. 2006,
45, 6041–6047. (c) Tsai, M.-L.; Liaw, W.-F. Inorg. Chem. 2006, 45,
6583–6585. (d) Tsou, C.-C.; Lu, T.-T.; Liaw, W.-F. J. Am. Chem.
Soc. 2007, 129, 12626–12627. (e) Lu, T.-T.; Tsou, C.-C.; Huang, H.-
W.; Hsu, I.-J.; Chen, J.-M.; Kuo, T.-S.; Wang, Y.; Liaw, W.-F. Inorg.
Chem. 2008, 47, 6040–6050. (f) Huang, H.-W.; Tsou, C.-C.; Kuo,
T.-S.; Liaw, W.-F. Inorg. Chem. 2008, 47, 2196–2204.
(21) D’Addario, S.; Demartin, F.; Grossi, L.; Iapalucci, M. C.; Laschi, F.;
Longoni, G.; Zanello, P. Inorg. Chem. 1993, 32, 1153–1160.
(22) (a) Chu, C. T. W.; Lo, F. Y. K.; Dahl, L. F. J. Am. Chem. Soc. 1982,
104, 3409–3422. (b) Kalyvas, H.; Coucouvanis, D. Inorg. Chem. 2006,
45, 8462–8464.
(13) Sellers, V. M.; Johnson, M. K.; Dailey, H. A. Biochemistry 1996, 35,
2699–2704.
(14) (a) Ding, H.; Demple, B. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 5146–
5150. (b) Yang, W.; Rogers, P. A.; Ding, H. J. Biol. Chem. 2002,
277, 12868–12873. (c) Bouton, C.; Chauveau, M.-J.; Lazereg, S.;
Drapier, J.-C. J. Biol. Chem. 2002, 277, 31220–31227.
(15) (a) Rao, P. V.; Holm, R. H. Chem. ReV. 2004, 104, 527–559. (b)
Mayerle, J. J.; Denmark, S. E.; DePamphilis, B. V.; Ibers, J. A.; Holm,
R. H. J. Am. Chem. Soc. 1975, 97, 1032–1045. (c) Hagen, K. S.;
Watson, A. D.; Holm, R. H. J. Am. Chem. Soc. 1983, 105, 3905–
3913. (d) Maelia, L. E.; Millar, M.; Koch, S. A. Inorg. Chem. 1992,
31, 4594–4600. (e) Chang, S.; Koch, S. A. J. Inorg. Biochem. 2007,
101, 1758–1759.
9
J. AM. CHEM. SOC. VOL. 130, NO. 50, 2008 17155